Natco Pharma is a leading company for the launch of various different generic medicines like Epclusa velpanat tablets. As per the recent developments, the company has made an announcement regarding the launch of the first generic form of Epclusa velpanat (Velpatasvir 100 mg and Sofosbuvir 400 mg) for the cure of Hepatitis C.

Natco Pharma is a leading company for the launch of various different generic medicines like Epclusa velpanat tablets. As per the recent developments, the company has made an announcement regarding the launch of the first generic form of Epclusa velpanat (Velpatasvir 100 mg and Sofosbuvir 400 mg) for the cure of Hepatitis C.

The Epclusa velpanat is the generic version of US Company Gilead Sciences new drug is called Epclusa. The generic velpanat tablets are helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.

Natco recently signed a non-exclusive licensing agreement with Gilead Sciences in order to manufacture and sell velpanat tablets, generic chronic hepatitis C drugs in 101 developing nations. This is in the fixed-dose combination for the patients who are suffering from the chronic Hepatitis C.

Side effects of velpatasvir:

•    Fatigue
•    A headache
•    Insomnia
•    Anemia
•    Nausea

How did Velpanat Tablets work?

Since velpatasvir is an antiviral medicine, it aids by lowering the amount of hepatitis C in the body and removing the virus completely from the blood vessels after some time